Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Prospective Clinical Study of KSH01-TCR-T in the Treatment of Refractory/Recurrent Solid Tumors

NCT05539833 is registered in ClinicalTrials.gov with TCRx Therapeutics Co.Ltd as lead sponsor.

NCT NCT05539833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05539833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Prospective Clinical Study of KSH01-TCR-T in the Treatment of Refractory/Recurrent Solid Tumors
Lead sponsor
TCRx Therapeutics Co.Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
August 19, 2022
Completion date
July 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory solid tumors, relapsed solid tumors, tcr-t cells